PROGESTERONE

Information current as at: 1 April 2026

No activity by the pharmaceutical company has been recorded for this medicine for six(6) months. The process for listing is considered inactive.

Legend:

Completed N In progress

Not applicable N Yet to commence

Submission Details

Brand name:: Utrogestan®
Form and strength:: Please search for and view the medicine's Public Summary Document (PSD) for more information
Condition/indication: (therapeutic use): Luteal phase support
Listing requested:: Please see PSD for more information
Funding program:: Please see PSD for more information
Request authority level:: Please see PSD for more information
PBAC submission type:: New PBS listing (Category 4)
Comment:: --
Submission sponsor:: BESINS HEALTHCARE AUSTRALIA PTY LTD
Other PBAC consideration:: --

Submission received for:: July 2024 PBAC meeting
Opportunity for consumer comment:: Open 03/04/2024 and close 29/05/2024 (see PBS Website)
PBAC meeting:: Held on 10/07/2024
PBAC outcome published:: Recommended (see PBAC Outcomes)
Notice of intent submitted:: 09/08/2024
5Lodgement of required documentation:: 21/08/2024
Acceptance of complete documentation:: Not Accepted
6Agreement to listing arrangements:: Has not yet commenced
7Government processes:: Has not yet commenced
8Medicine listed on the PBS:: Has not yet occurred

PBAC Recommendation:

Please see the Outcomes from the relevant meeting for more information

Public Summary Document:

Case ID: a895

Page last updated: 31 March 2026

v.9.19